Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
Journal of Hematology & Oncology
|
August 9, 2020
The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma
Samrat Roy Choudhury, Cody Ashby, Ruslana Tytarenko, et al.
Haematologica
|
November 20, 2023
Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma
Silvia Marino, Daniela N Petrusca, Ryan T Bishop, et al.
Blood Cancer Journal
|
May 31, 2022
Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
Cody Ashby, Eileen M Boyle, Michael A Bauer, et al.
Oncotarget
|
February 19, 2019
Poor overall survival in hyperhaploid multiple myeloma is defined by double-hit bi-allelic inactivation of <i>TP53</i>
Cody Ashby, Ruslana G Tytarenko, Yan Wang, et al.
Nature Communications
|
August 3, 2022
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
Leo Rasche, Carolina Schinke, Francesco Maura, et al.
The Journal of Clinical Investigation
|
June 1, 2021
TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies
Can Li, Jiliang Xia, Reinaldo Franqui-Machin, et al.
Cancer Biomarkers : Section a of Disease Markers
|
June 9, 2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma
Fumou Sun, Yan Cheng, Catherine Ma, et al.
Blood Cancer Journal
|
October 16, 2025
Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans
David E Mery, Guido Tricot, Samer Al Hadidi, et al.
Seminars in Cell & Developmental Biology
|
May 7, 2021
Chromothripsis as a pathogenic driver of multiple myeloma
Francesco Maura, Eileen M Boyle, Even H Rustad, et al.
Haematologica
|
November 28, 2024
A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma
Aric Anloague, Hayley M Sabol, Japneet Kaur, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
Journal of Hematology & Oncology
|
August 9, 2020
The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma
Samrat Roy Choudhury, Cody Ashby, Ruslana Tytarenko, et al.
Haematologica
|
November 20, 2023
Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma
Silvia Marino, Daniela N Petrusca, Ryan T Bishop, et al.
Blood Cancer Journal
|
May 31, 2022
Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
Cody Ashby, Eileen M Boyle, Michael A Bauer, et al.
Oncotarget
|
February 19, 2019
Poor overall survival in hyperhaploid multiple myeloma is defined by double-hit bi-allelic inactivation of <i>TP53</i>
Cody Ashby, Ruslana G Tytarenko, Yan Wang, et al.
Nature Communications
|
August 3, 2022
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
Leo Rasche, Carolina Schinke, Francesco Maura, et al.
The Journal of Clinical Investigation
|
June 1, 2021
TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies
Can Li, Jiliang Xia, Reinaldo Franqui-Machin, et al.
Cancer Biomarkers : Section a of Disease Markers
|
June 9, 2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma
Fumou Sun, Yan Cheng, Catherine Ma, et al.
Blood Cancer Journal
|
October 16, 2025
Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans
David E Mery, Guido Tricot, Samer Al Hadidi, et al.
Seminars in Cell & Developmental Biology
|
May 7, 2021
Chromothripsis as a pathogenic driver of multiple myeloma
Francesco Maura, Eileen M Boyle, Even H Rustad, et al.
Haematologica
|
November 28, 2024
A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma
Aric Anloague, Hayley M Sabol, Japneet Kaur, et al.
Page
of 6